Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
出版年份 2021 全文链接
标题
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
作者
关键词
-
出版物
HEADACHE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-07-26
DOI
10.1111/head.14194
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
- (2021) Messoud Ashina et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
- (2020) Stewart J Tepper et al. CEPHALALGIA
- Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients
- (2020) Piero Barbanti et al. CEPHALALGIA
- One-year sustained efficacy of erenumab in episodic migraine
- (2020) Peter J. Goadsby et al. NEUROLOGY
- Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura
- (2020) Claudia Altamura et al. CEPHALALGIA
- LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY
- (2020) Peter J. Goadsby et al. NEUROLOGY
- Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
- (2020) Richard B Lipton et al. CEPHALALGIA
- Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study
- (2020) Piero Barbanti et al. HEADACHE
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Real-world insights on the management of migraine patients: an Italian nationwide study
- (2019) Elio Agostoni et al. CURRENT MEDICAL RESEARCH AND OPINION
- Erenumab: A First-in-Class Monoclonal Antibody for Migraine Prevention
- (2019) Scott G. Garland et al. ANNALS OF PHARMACOTHERAPY
- Effects of Anti-Calcitonin Gene-Related Peptide for Migraines: A Systematic Review with Meta-Analysis of Randomized Clinical Trials
- (2019) I-Hsin Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trigeminal‐Targeted Treatments in Migraine: Is 60% the Magic Number?
- (2019) Piero Barbanti et al. HEADACHE
- Current and emerging evidence-based treatment options in chronic migraine: a narrative review
- (2019) Elio Clemente Agostoni et al. JOURNAL OF HEADACHE AND PAIN
- Mechanisms of migraine as a chronic evolutive condition
- (2019) Anna P. Andreou et al. JOURNAL OF HEADACHE AND PAIN
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Female sex hormones in men with migraine
- (2018) Willebrordus P.J. van Oosterhout et al. NEUROLOGY
- Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018
- (2018) Elizabeth Loder et al. HEADACHE
- A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
- (2018) Angelo Camporeale et al. BMC Neurology
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interictal burden attributable to episodic headache: findings from the Eurolight project
- (2016) Christian Lampl et al. JOURNAL OF HEADACHE AND PAIN
- Systematic Review of Migraine Prophylaxis Adherence and Persistence
- (2016) Zsolt Hepp et al. JOURNAL OF MANAGED CARE PHARMACY
- OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
- (2015) Eva Cernuda-Morollón et al. PAIN
- Preventive Pharmacotherapy in Migraine
- (2013) Paul Rizzoli HEADACHE
- Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study
- (2013) Giulia Giannini et al. JOURNAL OF HEADACHE AND PAIN
- Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
- (2013) E. Cernuda-Morollon et al. NEUROLOGY
- Testosterone pellet implants and migraine headaches: A pilot study
- (2012) Rebecca Glaser et al. MATURITAS
- Understanding Migraine through the Lens of Maladaptive Stress Responses: A Model Disease of Allostatic Load
- (2012) David Borsook et al. NEURON
- CGRP receptor antagonism and migraine
- (2010) Lars Edvinsson et al. Neurotherapeutics
- Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice
- (2009) Katharina Eikermann-Haerter et al. ANNALS OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now